CEACAM1 is well-known as a tumor-associated antigen over-expressed primarily in colorectal cancers but also in breast cancer (32), and it has been shown to activate inflammatory responses and promote differentiation of human macrophages (29, 33). Here, CEACAM1 is linked to breast cancer.